UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 3, 2017
 
 
U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
 
 
 
         
Nevada
 
1-11151
 
76-0364866
(State or other jurisdiction
of incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
     
1300 West Sam Houston Parkway South,
Suite 300, Houston, Texas
 
77042
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant's telephone number, including area code: (713) 297-7000
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
                                                                                                                   Emerging growth company                    ☐                  
   
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

Item 5.07 Submission of Matters to a Vote of Security Holdders.
 
The Annual Meeting of Stockholders (the "Annual Meeting") of U.S. Physical Therapy, Inc. (the "Company") was held on October 3, 2017. At the Annual Meeting, the Company's stockholders approved the four proposals, two of which are non-binding, which are described in detail in the company's definitive proxy statement dated August 15, 2017 ("Definitive Proxy"). Absentions and broker non-votes were counted for purposes of determining whether a quorom was present.
 
 
The results are as follows:

Proposal 1 - Election of nine directors to serve until the next annual meeting of stockholders.
 
     
Votes
Broker
Nominees
 
Votes For
Withheld
Non-Votes
Jerald L. Pullins
 
 9,606,711
1,189,665
       653,345
Christopher J. Reading
 
 10,704,930
 91,446
       653,345
Lawrance W. McAfee
 
 9,007,980
 1,788,396
       653,345
Mark J. Brookner
 
 10,003,267
 793,109
       653,345
Harry S. Chapman
 
 10,130,276
 666,100
       653,345
Bernard A. Harris, Jr.
 
 10,418,068
 378,308
       653,345
Edward L. Kuntz
 
 10,704,222
 92,154
       653,345
Regg E. Swanson
 
 10,283,389
 512,987
       653,345
Clayton K. Trier
 
 9,868,178
 928,198
       653,345
   
    
  
    
 
    Proposal 2 - Advisory vote to approve named executive officer compensation.
 
 
Votes
Votes
Broker
Votes For
Against
Abstaining
Non-Votes
  7,330,503
       3,459,426
           6,447
       653,345
 
    Proposal 3 - Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2017.
 
 
Votes
Votes
 
Votes For
Against
Abstaining
 
  11,406,902
       40,298
           2,521
       
 
 
    Proposal 4 - Recommendation, by non-binding vote, of the frequency of non-binding executive compensation votes.
 
Votes
Votes
Votes                                        
  Votes   
Broker
1 Year
2 Years
3 Years                                            
 Abstaining
Non-Votes
  10,204,992 
      46,742
          541,178                                    
 3,464
       653,345
 
 
Based on these results and consistent with a majority of votes cast with respect to this matter, the Company's Board of Directors will continue its policy to hold an advisory vote on compensation of named executive officers each year.
 
With respect to proposal 1, broker non-votes were not treated as a vote for or against any particular nominee and did not affect the outcome of the election of directors. With Proposal 2 and Proposal 4, broker non-votes did not have any effect on the outcome of the vote.
 
   
 
 
 
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
             
 
 
 
 
U.S. PHYSICAL THERAPY, INC.
       
Dated: October 3, 2017
 
 
 
By:
 
/s/ LAWRANCE W. MCAFEE
 
 
 
 
 
 
Lawrance W. McAfee
 
 
 
 
 
 
Chief Financial Officer
 
 
 
 
 
 
(duly authorized officer and principal financial
           and accounting officer)